Cytonus Therapeutics has filed a notice of an exempt offering of securities to raise $21,603,089.00 in New Equity Investment.
According to filings with the U.S. Securities and Exchange Commission, Cytonus Therapeutics is raising $21,603,089.00 in new funding. Sources indicate that as part of senior management President, Remo Moomiaie played a key role in securing…